• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page
Charles Joseph
Reaction score
0

Profile posts Latest activity Postings About

  • There are no messages on Charles Joseph's profile yet.
  • Loading…
  • Loading…
  • Loading…